Eng. Nizar Al-Hariri comes with over 25 years of successful track record of business development in both government and private sectors. Experienced across all aspects of business developments from concept to JV set-ups, contractual negotiations and funding arrangements to major project management, strategic planning and organization structuring. He has proven ability in developing business strategies and plans based on exceptional analytical skills, achieving business goals and taking full P&L responsibility.
Having worked in SIDF for ten years and managed Capital Advisory Group for five, he has a recognized management and consultancy records appointed him to manage the advisory services for the Economic Offset Program, EOP and Public Investment Fund, PIF between 2003 and 2006. Later, Eng. Al-Hariri was assigned as CEO for CAD Middle East for Pharmaceutical Industries. He was responsible for introducing a ground breaking concept of building the first GMP Active Pharmaceutical Ingredients (API) facility in Saudi Arabia and MENA region. He joined the Industrial Cluster (IC) in 2015 as VP for Pharma and Biotech and currently is IC President. Eng. Al Hariri also represents MEIM in board member in the Saudi FDA.
Eng. Nizar Al-Hariri has a BSc in Chemical Engineering from King Saud University and a high degree from the University of Cambridge, Engineering Dept. in Design, Manufacture & Management.